# FDA Inspection 1231202 - American National Red Cross - March 21, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/db7d9d34-8801-4d57-8fde-6d539ea79c9f
Source feed: FDA_Inspections

> FDA Inspection 1231202 for American National Red Cross on March 21, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231202
- Company Name: American National Red Cross
- Inspection Date: 2024-03-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1119514 - 2020-01-17](https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/ed5c0f29-9c62-4349-b32c-811a32ec1bc0)
- [FDA Inspection 997592 - 2016-12-09](https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/76261f8b-dade-436e-95f7-f9b274795c75)
- [FDA Inspection 800245 - 2012-08-22](https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/002a294f-7d20-417d-b730-f37baaa5a2a4)
- [FDA Inspection 682668 - 2010-09-24](https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/ef40146f-84f2-4110-b33b-79b4a8b21bd6)
- [FDA Inspection 546890 - 2008-12-10](https://www.globalkeysolutions.net/records/fda_inspections/american-national-red-cross/3e5db1fd-f95d-41ce-9967-5e64849162f9)

Company: https://www.globalkeysolutions.net/companies/american-national-red-cross/f594f1d0-c910-4589-9b3f-3668d11d29b7

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
